Tuesday October 9, 2018 0 comments
ENGLEWOOD -- Zynex, Inc. (OTCQB: ZYXI), a medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has obtained a U.S. utility patent for its Blood Volume Monitor Device.
Thomas Sandgaard, device inventor and company CEO, assigned the patent to Zynex's subsidiary, Zynex Monitoring Solutions.
"I am excited to have obtained patent protection for the core principles of how we detect fluid imbalances such as excessive blood loss during surgery or internal bleeding in recovery,” said Sandgaard.
“The algorithm which computes multiple vital signs into an easy-to-understand Index is now protected through this patent. This breakthrough technology is unique as there are no other non-invasive devices available that can detect blood loss or internal bleeding.
“We believe our non-invasive, easy-to-operate technology will serve a huge unmet need to manage blood volume in hospital and surgical settings, whether it is fluid loss, fluid overload or internal bleeding which is rarely detected until it becomes critical or fatal.
“We have previously received a strong interest in our Blood Volume Monitor from the U.S. Army when we provided them with a live demonstration of the product that is fully developed and in pilot production.
“It should be noted, we are still awaiting FDA clearance and European CE marking to fully launch the product into the market.
“We believe lives can be saved with this technology as significant complications are avoided during surgery. Fluid management issues can cause organs to malfunction and make recovery more difficult.
“We are pushing for getting additional claims patented to strengthen our intellectual property position as well as awaiting the results of our European patent application," Sandgaard said.
Founded in 1996, Zynex markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation and the company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients.
Zynex said it is also developing a new blood volume monitor for use in hospitals and surgery centers.